Boris Birmaher MD

Dr. Birmaher is a Distinguished Professor of Psychiatry, holds an Endowed Chair in Early Onset Bipolar Disease, and is an expert on the psychopharmacology and neurobiology of early-onset mood and anxiety disorders. He is the Director of the Child and Adolescent Bipolar Services Clinic (CABS). He has been a Principal Investigator or Co-Investigator on several major, multi-site clinical trials, including the Child/Adolescent Anxiety Multimodal Study (CAMS), Treatment of Early-onset Mania (TEAM), and Treatment of Resistant Depression in Adolescents (TORDIA). Dr. Birmaher has led two longitudinal (20 years) NIMH-funded projects on bipolar disorders; Course and Outcome for Adolescents with Bipolar Illness (COBI) which looked at the phenomenology and course and Children of Bipolar Parents: A High-Risk Follow-Up Study (BIOS) which looked at familial transmission. Dr. Birmaher has received numerous awards for his research and clinical work among which are the Colvin Prize for Outstanding Achievement in Mood Disorders Research from the Brain and Behavior Research Foundation, the Simon Bolivar Award for contributions and exceptional achievements in the field from the American Psychiatric Association and the Golden Apple Award for the Best Faculty Teacher of Residents which he has been honored with twice.  Between 2014 and 2018 he was the Chair to the Program Committee of the American Academy of Child and Adolescent Psychiatry, and currently is a board member of this association. Dr Birmaher has published over 480 papers in peer-review journals as well as numerous book chapters. Dr. Birmaher has taught and mentored numerous residents and research fellows from the United States and from around the world.